Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- PharmaEssentia Lays Out Sales Organization in Japan for 1st Product Launch
February 20, 2023
- Susmed Bags Japan Approval for Insomnia App
February 20, 2023
- IQVIA Pledges Push to Biopharma Startups in Japan
February 20, 2023
- Global PIII Launched for Xocova in Hospitalized Patients: Shionogi
February 20, 2023
- Mitsubishi Chemical Ups Full-Year Outlook on Gilenya Royalty Win
February 20, 2023
- Shareholders OK Nichi-Iko’s Delisting, Turnaround under New Management; President to Exit March 8
February 20, 2023
- Healios Cuts 40 % of Employees Due to MultiStem Development Glitches
February 17, 2023
- Nippon Shinyaku Grabs Japan Rights to Capricor’s DMD Cell Therapy
February 17, 2023
- ViiV Eyes More Uptake for Japan’s 1st Long-Acting HIV Med, Revs Up Development Drive
February 17, 2023
- As Global Race Heats Up for RAS Drugs, Japan Players Joining Fray with New Modalities
February 15, 2023
- Mitsubishi Tanabe Wins Arbitration Case over Gilenya Royalty
February 15, 2023
- Otsuka’s Pharma Sales Up 16.4% in 2022 on Global Brands, Hits 2023 Target 1 Year Earlier
February 15, 2023
- Fujifilm Begins Japan PIII for Stem Cell Therapy in Meniscus Injuries
February 15, 2023
- Mitsubishi Chemical Scraps Muse Cell Therapy Program
February 15, 2023
- Sawai President Sounds Negative about M&As, but Agrees Generic Industry Needs Consolidation
February 14, 2023
- Asahi Kasei Pharma Poised for a String of Approvals and Launch in 2023
February 14, 2023
- Sawai President Declares Plan to Raise Shipment Prices in FY2023
February 14, 2023
- Zeria to Take over Japan Marketing Authorization for Dafclir from Astellas
February 14, 2023
- AbbVie Rolls Out Skyrizi Auto-Doser in Japan
February 14, 2023
- Adcetris Filed for CTCL Indication in Japan: Takeda
February 14, 2023
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…